These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29678867)

  • 21. Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study.
    Zhang X; Cheng Z; Xiao Z; Du X; Du J; Li Y; Long Y; Yu H; Zhang X; Tian H
    Arch Med Res; 2015 May; 46(4):303-9. PubMed ID: 26087171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.
    Betzel B; Koehestanie P; Homan J; Aarts EO; Janssen IM; de Boer H; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2017 Feb; 85(2):409-415. PubMed ID: 27451295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial.
    Petry TZ; Fabbrini E; Otoch JP; Carmona MA; Caravatto PP; Salles JE; Sarian T; Correa JL; Schiavon CA; Patterson BW; Cohen R; Klein S
    Obesity (Silver Spring); 2015 Oct; 23(10):1973-9. PubMed ID: 26414562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes.
    Cohen RV; Neto MG; Correa JL; Sakai P; Martins B; Schiavon CA; Petry T; Salles JE; Mamedio C; Sorli C
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E279-82. PubMed ID: 23337729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A perspective on metabolic surgery from a gastroenterologist.
    Syu YF; Inui A; Chen CY
    J Pharmacol Sci; 2017 Feb; 133(2):61-64. PubMed ID: 28237320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
    Balint IB; Csaszar F; Somodi K; Ternyik L; Biro A; Kaposztas Z
    Langenbecks Arch Surg; 2021 Aug; 406(5):1363-1377. PubMed ID: 33712874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.
    Ruban A; Miras AD; Glaysher MA; Goldstone AP; Prechtl CG; Johnson N; Chhina N; Al-Najim W; Aldhwayan M; Klimowska-Nassar N; Smith C; Lord J; Li JV; Flores L; Al-Lababidi M; Dimitriadis GK; Patel M; Moore M; Chahal H; Ahmed AR; Cousins J; Aldubaikhi G; Glover B; Falaschetti E; Ashrafian H; Roux CWL; Darzi A; Byrne JP; Teare JP
    Ann Surg; 2022 Mar; 275(3):440-447. PubMed ID: 34647708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
    Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes.
    Rodriguez L; Reyes E; Fagalde P; Oltra MS; Saba J; Aylwin CG; Prieto C; Ramos A; Galvao M; Gersin KS; Sorli C
    Diabetes Technol Ther; 2009 Nov; 11(11):725-32. PubMed ID: 19905889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.
    Nosso G; Griffo E; Cotugno M; Saldalamacchia G; Lupoli R; Pacini G; Riccardi G; Angrisani L; Capaldo B
    Horm Metab Res; 2016 May; 48(5):312-7. PubMed ID: 26788926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
    Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D
    Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.
    Cohen R; le Roux CW; Papamargaritis D; Salles JE; Petry T; Correa JL; Pournaras DJ; Galvao Neto M; Martins B; Sakai P; Schiavon CA; Sorli C
    Diabet Med; 2013 Dec; 30(12):1482-6. PubMed ID: 23802863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
    Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
    Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.
    Huang CK; Tai CM; Chang PC; Malapan K; Tsai CC; Yolsuriyanwong K
    Obes Surg; 2016 Oct; 26(10):2291-301. PubMed ID: 26935711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis.
    Patel RT; Shukla AP; Ahn SM; Moreira M; Rubino F
    Obesity (Silver Spring); 2014 Jan; 22(1):159-69. PubMed ID: 23512969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.